Jason Wittes
Stock Analyst at Roth Capital
(2.69)
# 2,188
Out of 5,093 analysts
61
Total ratings
49.06%
Success rate
4.83%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $9.95 | +302.21% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $349.23 | +30.57% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.73 | +824.86% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $2.84 | +463.38% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $15.65 | +40.58% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $96.76 | -25.59% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $6.90 | +59.42% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $88.42 | +30.06% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $12.50 | +188.00% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $8.13 | +35.30% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.08 | +825.93% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $82.89 | +20.64% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.38 | +110.08% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.99 | +812.22% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $27.04 | +177.37% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $20.67 | +6.43% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $92.27 | +30.05% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $138.62 | +48.61% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $177.15 | -18.15% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $17.85 | -15.97% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $12.70 | +1,474.80% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $30.43 | -14.56% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $9.95
Upside: +302.21%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $349.23
Upside: +30.57%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.73
Upside: +824.86%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $2.84
Upside: +463.38%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.65
Upside: +40.58%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $96.76
Upside: -25.59%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $6.90
Upside: +59.42%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $88.42
Upside: +30.06%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.50
Upside: +188.00%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $8.13
Upside: +35.30%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.08
Upside: +825.93%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $82.89
Upside: +20.64%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.38
Upside: +110.08%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $0.99
Upside: +812.22%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $27.04
Upside: +177.37%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $20.67
Upside: +6.43%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $92.27
Upside: +30.05%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $138.62
Upside: +48.61%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $177.15
Upside: -18.15%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $17.85
Upside: -15.97%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $12.70
Upside: +1,474.80%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $30.43
Upside: -14.56%